Mark G. Waugh

1.9k total citations
40 papers, 1.5k citations indexed

About

Mark G. Waugh is a scholar working on Molecular Biology, Cell Biology and Physiology. According to data from OpenAlex, Mark G. Waugh has authored 40 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 26 papers in Cell Biology and 6 papers in Physiology. Recurrent topics in Mark G. Waugh's work include Cellular transport and secretion (21 papers), Lipid Membrane Structure and Behavior (13 papers) and Protein Kinase Regulation and GTPase Signaling (7 papers). Mark G. Waugh is often cited by papers focused on Cellular transport and secretion (21 papers), Lipid Membrane Structure and Behavior (13 papers) and Protein Kinase Regulation and GTPase Signaling (7 papers). Mark G. Waugh collaborates with scholars based in United Kingdom, Switzerland and Italy. Mark G. Waugh's co-authors include J. Justin Hsuan, Shane Minogue, Durward Lawson, Emma L. Clayton, J. Simon Anderson, Fedor Berditchevski, Maria Antonietta De Matteis, David Stephens, Rainer Cramer and Andrew Hall and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemical Journal.

In The Last Decade

Mark G. Waugh

38 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark G. Waugh United Kingdom 24 1.0k 787 191 175 159 40 1.5k
Sharron X. Lin United States 16 861 0.8× 783 1.0× 182 1.0× 92 0.5× 248 1.6× 33 1.4k
Richard Lin United States 15 1.1k 1.1× 878 1.1× 158 0.8× 108 0.6× 114 0.7× 27 2.0k
Eduard Stefan Austria 26 1.9k 1.9× 434 0.6× 121 0.6× 144 0.8× 120 0.8× 60 2.3k
Mikel Garcia‐Marcos United States 29 1.9k 1.8× 458 0.6× 98 0.5× 181 1.0× 229 1.4× 77 2.4k
Antonello D’Arrigo Italy 20 1.5k 1.4× 881 1.1× 330 1.7× 175 1.0× 186 1.2× 22 2.5k
Lawrence D. Schweitzer United States 9 920 0.9× 309 0.4× 115 0.6× 120 0.7× 81 0.5× 10 1.3k
Martijn Gloerich Netherlands 22 852 0.8× 466 0.6× 122 0.6× 45 0.3× 128 0.8× 27 1.5k
Christine Lavoie Canada 20 801 0.8× 474 0.6× 160 0.8× 49 0.3× 78 0.5× 43 1.2k
Theodor Hanck Germany 16 978 1.0× 206 0.3× 110 0.6× 259 1.5× 62 0.4× 19 1.4k
Oliver B. Davis United States 8 448 0.4× 279 0.4× 226 1.2× 189 1.1× 128 0.8× 9 907

Countries citing papers authored by Mark G. Waugh

Since Specialization
Citations

This map shows the geographic impact of Mark G. Waugh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark G. Waugh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark G. Waugh more than expected).

Fields of papers citing papers by Mark G. Waugh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark G. Waugh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark G. Waugh. The network helps show where Mark G. Waugh may publish in the future.

Co-authorship network of co-authors of Mark G. Waugh

This figure shows the co-authorship network connecting the top 25 collaborators of Mark G. Waugh. A scholar is included among the top collaborators of Mark G. Waugh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark G. Waugh. Mark G. Waugh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kleyman, Anna, Waqas Khaliq, Daniel A. Hofmaenner, et al.. (2025). Sepsis-induced hypocholesterolemia is linked to low cardiomyocyte membrane cholesterol and impaired catecholamine responsiveness. Critical Care. 29(1). 399–399.
3.
Waugh, Mark G.. (2019). The Great Escape: how phosphatidylinositol 4-kinases and PI4P promote vesicle exit from the Golgi (and drive cancer). Biochemical Journal. 476(16). 2321–2346. 56 indexed citations
4.
Gewinner, Christina, et al.. (2016). Phosphatidylinositol 4-kinase IIβ negatively regulates invadopodia formation and suppresses an invasive cellular phenotype. Molecular Biology of the Cell. 27(25). 4033–4042. 15 indexed citations
6.
Waugh, Mark G.. (2015). Measuring Phosphatidylinositol Generation on Biological Membranes. Methods in molecular biology. 1376. 239–246. 3 indexed citations
7.
Waugh, Mark G.. (2014). Chromosomal Instability and Phosphoinositide Pathway Gene Signatures in Glioblastoma Multiforme. Molecular Neurobiology. 53(1). 621–630. 27 indexed citations
9.
Waugh, Mark G.. (2013). Raft-like membranes from the trans-Golgi network and endosomal compartments. Nature Protocols. 8(12). 2429–2439. 18 indexed citations
10.
Clayton, Emma L., Shane Minogue, & Mark G. Waugh. (2013). Mammalian phosphatidylinositol 4-kinases as modulators of membrane trafficking and lipid signaling networks. Progress in Lipid Research. 52(3). 294–304. 60 indexed citations
11.
Clayton, Emma L., Shane Minogue, & Mark G. Waugh. (2012). Phosphatidylinositol 4-Kinases and PI4P Metabolism in the Nervous System: Roles in Psychiatric and Neurological Diseases. Molecular Neurobiology. 47(1). 361–372. 28 indexed citations
12.
Minogue, Shane & Mark G. Waugh. (2012). Lipid rafts, microdomain heterogeneity and inter‐organelle contacts: Impacts on membrane preparation for proteomic studies. Biology of the Cell. 104(10). 618–627. 9 indexed citations
13.
Waugh, Mark G.. (2012). Phosphatidylinositol 4-kinases, phosphatidylinositol 4-phosphate and cancer. Cancer Letters. 325(2). 125–131. 39 indexed citations
14.
Waugh, Mark G., Shane Minogue, Emma L. Clayton, & J. Justin Hsuan. (2011). CDP-diacylglycerol phospholipid synthesis in detergent-soluble, non-raft, membrane microdomains of the endoplasmic reticulum. Journal of Lipid Research. 52(12). 2148–2158. 12 indexed citations
15.
Srirajaskanthan, Rajaventhan, Martyn Caplin, Mark G. Waugh, et al.. (2009). Identification of Mac-2-binding Protein as a Putative Marker of Neuroendocrine Tumors from the Analysis of Cell Line Secretomes. Molecular & Cellular Proteomics. 9(4). 656–666. 13 indexed citations
16.
Hsuan, J. Justin, Mark G. Waugh, & Shane Minogue. (2008). Phosphatidylinositol 4-kinase type II alpha. 1 indexed citations
17.
Waugh, Mark G., Shane Minogue, & J. Justin Hsuan. (2008). Quantification of Multiple Phosphatidylinositol 4-Kinase Isozyme Activities in Cell Extracts. Methods in molecular biology. 462. 1–11. 4 indexed citations
18.
Minogue, Shane, Mark G. Waugh, Maria Antonietta De Matteis, et al.. (2006). Phosphatidylinositol 4-kinase is required for endosomal trafficking and degradation of the EGF receptor. Journal of Cell Science. 119(3). 571–581. 112 indexed citations
19.
Waugh, Mark G., et al.. (2005). Lipid and Peptide Control of Phosphatidylinositol 4-Kinase IIα Activity on Golgi-endosomal Rafts. Journal of Biological Chemistry. 281(7). 3757–3763. 48 indexed citations
20.
Minogue, Shane, et al.. (2001). Cloning of a Human Type II Phosphatidylinositol 4-Kinase Reveals a Novel Lipid Kinase Family. Journal of Biological Chemistry. 276(20). 16635–16640. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026